vTv Therapeutics Inc. Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest
vTv Therapeutics Inc. (VTVT) reported Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest of -$1.33 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNonredeemableNoncontrollingInterest · last filed 2025-11-06
- vTv Therapeutics Inc. net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2025-06-30 was -$1.33M.
- vTv Therapeutics Inc. net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2025-03-31 was -$1.13M.
- vTv Therapeutics Inc. net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2024-09-30 was -$1.06M.
- vTv Therapeutics Inc. net income (loss) attributable to nonredeemable noncontrolling interest for the quarter ending 2024-06-30 was -$1.23M.
| Period end | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest 9 month as first filed |
|---|---|---|---|---|
| 2025-06-30 | -$1.33M 10-Q · filed 2025-08-12 | -$2.46M 10-Q · filed 2025-08-12 | ||
| 2025-03-31 | -$1.13M 10-Q · filed 2025-05-15 | |||
| 2024-09-30 | -$1.06M 10-Q · filed 2024-11-12 | -$2.29M derived: sum of 2 quarters · filed 2025-08-12 | $2.35M 10-Q · filed 2025-11-06 | -$2.35M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$1.23M 10-Q · filed 2025-08-12 | -$1.30M 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | -$69.00K 10-Q · filed 2024-05-09 |